Impact of the COVID-19 pandemic and vaccination on global, regional, and national burden of Guillain-Barré syndrome: observational study

Xīn Gào, Chen Zhao, Junting Yang, Ziming Yang, et. al. ,doi: https://doi.org/10.1101/2024.07.09.24309613 Objectives To estimate the global, regional, and national burden and trends of Guillain-Barré Syndrome (GBS), and to explore the impact of the COVID-19 pandemic and related public health…[...]

Read More

Bilateral Facial Paralysis in an Atypical Clinical Onset of COVID-Associated Guillain-Barre Syndrome

Ahmad Taftaf • Claudine A. Vera Cruz • Haytham Al-Qasmi • Mohammed Al-QasmiPublished: June 30, 2024, DOI: 10.7759/cureus.63498 Peer-Reviewed Abstract Coronavirus disease (COVID-19) has been associated with a diverse range of extrapulmonary manifestations since its global outbreak in 2019.…[...]

Read More

Covid-19: Two rare vaccine side effects detected in large global study

BMJ 2024; 384 doi: https://doi.org/10.1136/ bmj.q488 (2024) The largest vaccine safety study to date has identified two new, but very rare, side effects associated with covid-19 vaccines—transverse myelitis and acute disseminated encephalomyelitis. The Global Vaccine…[...]

Read More

Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain

Héctor Hernández-Parra1,2 Octavio Daniel Reyes-Hernández3 Gabriela Figueroa-González4 Manuel González-Del Carmen5 Maykel González-Torres6 Sheila I. Peña-Corona2 Benjamín Florán7 Hernán Cortés8* Gerardo Leyva-Gómez2* https://pubmed.ncbi.nlm.nih.gov/36998270/ Diverse neurological symptoms have been reported in patients with SARS-CoV-2 disease (COVID-19), including stroke, ataxia, meningitis,…[...]

Read More